Anna Djos

944 total citations
24 papers, 491 citations indexed

About

Anna Djos is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Anna Djos has authored 24 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 17 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Anna Djos's work include Neuroblastoma Research and Treatments (22 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Cancer therapeutics and mechanisms (9 papers). Anna Djos is often cited by papers focused on Neuroblastoma Research and Treatments (22 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Cancer therapeutics and mechanisms (9 papers). Anna Djos collaborates with scholars based in Sweden, Spain and Austria. Anna Djos's co-authors include Tommy Martinsson, Per Kogner, Helena Carén, Ruth H. Palmer, Bengt Hallberg, Susanne Fransson, Niloufar Javanmardi, Ana P. Berbegall, Rose‐Marie Sjöberg and Rosa Noguera and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Anna Djos

21 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Djos Sweden 13 330 317 175 126 52 24 491
Susanne Fransson Sweden 15 359 1.1× 309 1.0× 183 1.0× 126 1.0× 46 0.9× 38 542
Jessica Theißen Germany 12 515 1.6× 441 1.4× 377 2.2× 153 1.2× 44 0.8× 15 754
Crocifissa Lo Cunsolo Italy 10 227 0.7× 175 0.6× 103 0.6× 119 0.9× 34 0.7× 17 412
Deepa Khazi United States 5 291 0.9× 443 1.4× 234 1.3× 127 1.0× 65 1.3× 5 530
Alex Cazes France 9 206 0.6× 145 0.5× 102 0.6× 107 0.8× 21 0.4× 9 336
Erin R. Okawa United States 8 338 1.0× 198 0.6× 134 0.8× 86 0.7× 27 0.5× 13 492
Joshua Courtright United States 4 237 0.7× 192 0.6× 128 0.7× 123 1.0× 17 0.3× 6 380
Piero Pignataro Italy 10 155 0.5× 137 0.4× 107 0.6× 63 0.5× 31 0.6× 14 379
Garrett M. Brodeur United States 7 284 0.9× 346 1.1× 156 0.9× 97 0.8× 73 1.4× 8 506
Annika Sprüssel Germany 9 343 1.0× 144 0.5× 153 0.9× 89 0.7× 9 0.2× 10 477

Countries citing papers authored by Anna Djos

Since Specialization
Citations

This map shows the geographic impact of Anna Djos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Djos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Djos more than expected).

Fields of papers citing papers by Anna Djos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Djos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Djos. The network helps show where Anna Djos may publish in the future.

Co-authorship network of co-authors of Anna Djos

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Djos. A scholar is included among the top collaborators of Anna Djos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Djos. Anna Djos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Djos, Anna, et al.. (2025). DNA methylation profiling for molecular classification of neuroblastoma. Clinical Epigenetics. 17(1). 131–131.
2.
Fransson, Susanne, Anna Djos, Johanna Svensson, et al.. (2025). Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report. Frontiers in Oncology. 15. 1569520–1569520.
3.
4.
Djos, Anna, Johanna Svensson, Ganesh Umapathy, et al.. (2024). Loss of Chromosome Y in Neuroblastoma Is Associated With High‐Risk Disease, 11q‐Deletion, and Telomere Maintenance. Genes Chromosomes and Cancer. 63(7). e23260–e23260. 2 indexed citations
5.
Vaid, Roshan, Rebeca Burgos‐Panadero, Anna Djos, et al.. (2023). METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Research. 52(5). 2648–2671. 27 indexed citations
6.
Djos, Anna, Roshan Vaid, Ganesh Umapathy, et al.. (2023). Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes. Cancers. 15(24). 5732–5732. 3 indexed citations
7.
Djos, Anna, et al.. (2023). Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma. International Journal of Oncology. 62(2). 4 indexed citations
8.
Lai, Wei‐Yun, Anh T. Le, Susanne Fransson, et al.. (2022). Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC. Lung Cancer. 171. 103–114. 7 indexed citations
9.
Sillén, Ulla, et al.. (2022). Whole exome sequencing identifies KIF26B, LIFR and LAMC1 mutations in familial vesicoureteral reflux. PLoS ONE. 17(11). e0277524–e0277524. 2 indexed citations
10.
Berbegall, Ana P., Niloufar Javanmardi, Anna Djos, et al.. (2022). Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup. Scientific Reports. 12(1). 12420–12420. 16 indexed citations
11.
Javanmardi, Niloufar, Jimmy Van den Eynden, Susanne Fransson, et al.. (2020). 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma. Cell Reports. 32(12). 108171–108171. 28 indexed citations
12.
Javanmardi, Niloufar, Susanne Fransson, Anna Djos, et al.. (2019). Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment. Scientific Reports. 9(1). 2199–2199. 14 indexed citations
13.
Umapathy, Ganesh, Jikui Guan, Dan Gustafsson, et al.. (2017). MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas. Science Signaling. 10(507). 41 indexed citations
14.
Fransson, Susanne, Malin Östensson, Anna Djos, et al.. (2016). Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma. International Journal of Oncology. 48(3). 1103–1116. 17 indexed citations
15.
Berbegall, Ana P., Eva Villamón, Marta Piqueras, et al.. (2015). Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors. Oncogene. 35(11). 1423–1432. 21 indexed citations
16.
Villamón, Eva, Ana P. Berbegall, Marta Piqueras, et al.. (2013). Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion. PLoS ONE. 8(1). e53740–e53740. 33 indexed citations
17.
Djos, Anna, Susanne Fransson, Per Kogner, & Tommy Martinsson. (2013). Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene. BMC Medical Genetics. 14(1). 102–102. 5 indexed citations
18.
Djos, Anna, Tommy Martinsson, Per Kogner, & Helena Carén. (2012). The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma. Molecular Cancer. 11(1). 40–40. 62 indexed citations
19.
Schönherr, Christina, Kristina Ruuth, Sattu Kamaraj, et al.. (2012). Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells. Oncogene. 31(50). 5193–5200. 83 indexed citations
20.
Carén, Helena, Anna Djos, Maria Nethander, et al.. (2011). Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma. BMC Cancer. 11(1). 66–66. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Fransson Breakdown of academic impact, for papers by Jessica Theißen Breakdown of academic impact, for papers by Crocifissa Lo Cunsolo Breakdown of academic impact, for papers by Deepa Khazi Breakdown of academic impact, for papers by Alex Cazes Breakdown of academic impact, for papers by Erin R. Okawa Breakdown of academic impact, for papers by Joshua Courtright Breakdown of academic impact, for papers by Piero Pignataro Breakdown of academic impact, for papers by Garrett M. Brodeur Breakdown of academic impact, for papers by Annika Sprüssel
Rankless by CCL
2026